Numed Pharma

numedpharma.com

Numed Pharma is a nationwide wholesale pharmaceutical distributor with an established record of unshakable account management. Thanks to our unique approach to communications and service, we’ve come to dominate the drug industry as the Prime Drug Source for pharmacies nationally. With our large, growing and ambitious telemarketing sales team, Numed is the right work setting for anyone who's looking for a fast paced career in sales. In the biggest industry in the world, we have found the recipe for success. With an engaging remuneration package of base salary plus commission, being conveniently located next to public transport, and being easily accessible from anywhere in New York City, our working environment is one of the best in the prescription drug business.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

APTAR EXPANDS PHARMACEUTICAL SERVICES ANNOUNCES EXCLUSIVE COLLABORATION BETWEEN APTAR PHARMA AND FLUIDDA

Aptar Pharma and Fluidda | September 23, 2022

news image

Nanopharm, an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products announced an exclusive collaboration with Fluidda, a leader in the field of Functional Respiratory Imaging. The companies will leverage their respective proprietary technology platforms to help accelerate U.S. Food & Drug Administration approvals for orally inhaled generic products via the alternative bioequivalence pathway. Nanopharm was acquired by Aptar in...

Read More

Business Insights

TITAN PHARMACEUTICALS ANNOUNCES BOARD EXPANSION AND MANAGEMENT CHANGES

Titan Pharmaceuticals, Inc. | August 22, 2022

news image

Titan Pharmaceuticals, Inc. announced that it has expanded its Board of Directors from five to eleven and appointed six new directors following their election at its special meeting of stockholders held on August 15, 2022. The new directors, which were on a nominee slate proposed by Activist Investing LLC are Avraham Ben-Tzvi, Peter L. Chasey, Eric Greenberg, David E. Lazar, Matthew C. McMurdo and David Natan. In addition, following the Special Meeting, Mr. Lazar was appointed int...

Read More

Business Insights

VETSOURCE EXPANDS ITS SOLUTION SET TO INCLUDE DATA AND INSIGHTS, CLIENT ENGAGEMENT

Vetsource | February 28, 2022

news image

Vetsource®, a pet health company that provides innovative pharmacy, technology and business services designed to help customers provide products and services to those who care for pets, has added data and insights, and client engagement offerings to its portfolio of customer solutions. Previously focused primarily on the home delivery of prescription and nonprescription items on behalf of veterinary practices, Vetsource has expanded its services in order to build a world-class...

Read More

Pharmacy Market

ENTOS PHARMACEUTICALS ANNOUNCES SENIOR LEADERSHIP APPOINTMENTS TO EXPAND EXECUTIVE TEAM AND ACCELERATE GROWTH

Entos Pharmaceuticals | March 07, 2022

news image

EDMONTON, Alberta Entos Pharmaceuticals a clinical-stage biotechnology company developing genetic medicines with its Fusogenix proteolipid vehicle (PLV) nucleic acid delivery platform, today announced two executive-level appointments, Dr. Steve Chen as Chief Medical Officer (CMO) and Jason Ding as Chief Business Officer (CBO). Dr. Steve Chen brings over 20 years of academic research and pharmaceutical biotechnology experience across multiple therapeutic areas to Entos. He will be ...

Read More
news image

Business Insights

APTAR EXPANDS PHARMACEUTICAL SERVICES ANNOUNCES EXCLUSIVE COLLABORATION BETWEEN APTAR PHARMA AND FLUIDDA

Aptar Pharma and Fluidda | September 23, 2022

Nanopharm, an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products announced an exclusive collaboration with Fluidda, a leader in the field of Functional Respiratory Imaging. The companies will leverage their respective proprietary technology platforms to help accelerate U.S. Food & Drug Administration approvals for orally inhaled generic products via the alternative bioequivalence pathway. Nanopharm was acquired by Aptar in...

Read More
news image

Business Insights

TITAN PHARMACEUTICALS ANNOUNCES BOARD EXPANSION AND MANAGEMENT CHANGES

Titan Pharmaceuticals, Inc. | August 22, 2022

Titan Pharmaceuticals, Inc. announced that it has expanded its Board of Directors from five to eleven and appointed six new directors following their election at its special meeting of stockholders held on August 15, 2022. The new directors, which were on a nominee slate proposed by Activist Investing LLC are Avraham Ben-Tzvi, Peter L. Chasey, Eric Greenberg, David E. Lazar, Matthew C. McMurdo and David Natan. In addition, following the Special Meeting, Mr. Lazar was appointed int...

Read More
news image

Business Insights

VETSOURCE EXPANDS ITS SOLUTION SET TO INCLUDE DATA AND INSIGHTS, CLIENT ENGAGEMENT

Vetsource | February 28, 2022

Vetsource®, a pet health company that provides innovative pharmacy, technology and business services designed to help customers provide products and services to those who care for pets, has added data and insights, and client engagement offerings to its portfolio of customer solutions. Previously focused primarily on the home delivery of prescription and nonprescription items on behalf of veterinary practices, Vetsource has expanded its services in order to build a world-class...

Read More
news image

Pharmacy Market

ENTOS PHARMACEUTICALS ANNOUNCES SENIOR LEADERSHIP APPOINTMENTS TO EXPAND EXECUTIVE TEAM AND ACCELERATE GROWTH

Entos Pharmaceuticals | March 07, 2022

EDMONTON, Alberta Entos Pharmaceuticals a clinical-stage biotechnology company developing genetic medicines with its Fusogenix proteolipid vehicle (PLV) nucleic acid delivery platform, today announced two executive-level appointments, Dr. Steve Chen as Chief Medical Officer (CMO) and Jason Ding as Chief Business Officer (CBO). Dr. Steve Chen brings over 20 years of academic research and pharmaceutical biotechnology experience across multiple therapeutic areas to Entos. He will be ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us